The Dividend Protected Harbor: 2 Shares to Watch

IT’s been a lackluster 12 months thus far for U.S. equities. 12 months-to-date, the benchmark S&P 500 is barely within the pink, weighed down primarily by a selloff in Technology/”>mega-cap Technology. What started as a pause in management has advanced into broader volatility, and now, geopolitical tensions are including one other layer of uncertainty.

Over the weekend, a joint U.S.-Israel mission focusing on Iran considerably escalated tensions within the Center East. In response, markets have begun pricing in increased danger. Brent crude is buying and selling close to 52-week highs, the U.S. Greenback Index seems to have carved out a short-term backside, and the CBOE Volatility Index (VIX) is trying to interrupt out of a protracted consolidation vary.

Rising oil costs, a strengthening greenback, and increasing volatility sometimes don’t create a good backdrop for equities within the close to time period. If risk-off sentiment continues to construct, buyers might look to rebalance portfolios towards extra defensive positioning.

For these looking for stability and revenue amid lingering uncertainty, dividend-paying defensive stocks provide a possible secure harbor, significantly these with regular demand profiles and enticing valuations.

A healthcare big and a midstream operator test each bins.

Pfizer: Defensive Healthcare With Yield

Pfizer (NYSE: PFE) stands out for each its defensive positioning and its revenue attraction. Healthcare has been one of many major beneficiaries of capital rotation this 12 months, as buyers shift towards sectors much less delicate to macroeconomic swings. Pfizer has mirrored that pattern. The inventory has elevated by almost 9.5% year-to-date, considerably outpacing the general market.

Some of the compelling points of Pfizer’s profile is its dividend. The corporate at present gives a yield of 6.3%, nicely above the S&P 500 common. In an surroundings the place volatility is rising and development expectations are moderating, that stage of revenue turns into more and more enticing.

Essentially, outcomes have additionally been regular. In its Q4 2025 earnings report, Pfizer posted EPS of 66 cents, beating consensus estimates of 57 cents. Income got here in at $17.56 billion, barely down 12 months over 12 months however nonetheless forward of expectations. Whereas top-line development has moderated, the corporate continues to reveal earnings resilience.

Valuation additional strengthens the case. With a ahead P/E ratio of 9.6, Pfizer trades at a major low cost to the broader market. For long-term buyers looking for worth inside a defensive sector, that a number of seems compelling.

Institutional flows additionally counsel rising confidence. Over the previous 12 months, the inventory has seen $16.1 billion in inflows versus just below $12 billion in outflows, leading to roughly $4 billion in internet inflows. That regular accumulation reinforces the defensive narrative.

Power Switch: Yield and Sector Energy

Energy Transfer (NYSE: ET) gives a unique sort of defensive publicity, with the additional benefit of sector momentum. Primarily based in Dallas, Power Switch is a midstream power firm that develops and operates infrastructure for transporting, storing, and processing hydrocarbons. Its built-in community of pipelines, terminals, and storage services strikes pure gasoline, pure gasoline liquids, crude oil, and refined merchandise throughout North America.

Not like upstream producers, midstream firms are sometimes much less uncovered to commodity value volatility and as an alternative generate fee-based income tied to quantity. That construction can present relative stability, even in periods of value swings. That stated, rising oil costs act as a supportive tailwind for the broader energy sector. With crude oil buying and selling close to 52-week highs amid escalating geopolitical tensions, capital has aggressively rotated into power shares. The power sector is at present one of many strongest performers year-to-date, and Power Switch has participated in that power.

The inventory has just lately damaged out to new 52-week highs, clearing key resistance ranges on the every day chart. Shares have elevated by almost 16% year-to-date, strongly surpassing the efficiency of the S&P 500.

Revenue buyers may also word the corporate’s substantial dividend yield, at present close to 7%. With a ahead P/E ratio of round 11, the inventory gives a mix of revenue and cheap valuation. Wall Avenue sentiment aligns with the constructive value motion. Analysts preserve a Moderate Buy rating on the inventory, with a consensus value goal implying nearly 11% upside potential from present ranges.

Corporations Talked about in This Article:

Firm	Present Value	Value Change	Dividend Yield	P/E Ratio	Consensus Score	Consensus Value Goal
Pfizer (PFE)	$27.07	+1.7%	6.35%	19.90	Maintain	$28.05
Power Switch (ET)	$18.73	+0.3%	7.15%	15.48	Reasonable Purchase	$21.20

About Ryan Hasson

Expertise

Ryan Hasson has been a contributing writer for DividendStocks.com since 2023.

• Skilled Background: Ryan Hasson is an equities dealer and monetary markets commentator with a robust background in technical evaluation, momentum buying and selling, and danger administration. He has labored as an equities dealer at SMB Capital and as a enterprise evaluation guide at Zoom Worldwide, giving him a well-rounded view of each market dynamics and institutional technique.
• Credentials: He holds a Bachelor of Commerce in Monetary Administration.
• Finance Expertise: Ryan has been a contributing author for DividendStocks.com since 2023. He brings a number of years of expertise in fairness analysis and energetic buying and selling, providing well timed insights into inventory efficiency, investor sentiment, and technical market habits.
• Writing Focus: He covers tech shares, dividend methods, ETFs, and value-based alternatives, mixing short-term tactical views with long-term investing frameworks.
• Funding Strategy: Ryan combines technical and basic evaluation to identify momentum shifts, key entry and exit factors, and rising themes. His method emphasizes buying and selling psychology, self-discipline, and danger management.
• Inspiration: Ryan has a robust ardour for researching and analyzing monetary markets. He persistently stays knowledgeable on the most recent information and developments affecting each the broader market and particular person shares, utilizing that data to uncover buying and selling alternatives.
• Enjoyable Reality: He’s been featured on a number of buying and selling podcasts and retains a shortlist of favourite investing books, together with Reminiscences of a Inventory Operator, Market Wizards, and Widespread Shares and Unusual Earnings.
• Areas of Experience: Fairness analysis and evaluation, technical evaluation and value motion, market sentiment, danger administration

Schooling

Bachelor of Commerce in Monetary Administration